Showing 2251-2260 of 2735 results for "".
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- The Art of Saying Nohttps://modernaesthetics.com/news/the-art-of-saying-no/2473533/Most cosmetic dermatologists and plastic surgeons have encountered a patient (or patients) with unreasonable expectations and know intuitively that these patients won’t be satisfied with the outcome of a requested procedure. Still, it can be hard to say no, especially when the doc
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- Study: Lumenato Boosts Skin Barrier Function, Collagen and Ceramideshttps://modernaesthetics.com/news/study-lumenato-boosts-skin-barrier-function-collagen-and-ceramides/2473526/Lycored's Lumenato may improve the skin barrier function and boost collagen and ceramides after 12 weeks of daily supple
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo
- Study Highlights Benefits of Nonsurgical Rhinoplasty With PDO Max Threadshttps://modernaesthetics.com/news/study-highlights-benefits-of-nonsurgical-rhinoplasty-with-pdo-max-threads/2473521/Non-surgical rhinoplasty using polydioxanone (PDO) threads can safely achieve minor nasal changes especially in tip rotation and appearance of dorsal hump, according to research in the Journal of Cosmetic Dermatology. The pr
- AirSculpt Technologies Teams Up NYSYNC Member Joey Fatonehttps://modernaesthetics.com/news/airsculpt-technologies-teams-up-nysync-member-joey-fatone/2473508/AirSculpt Technologies, Inc. is partnering with singer, dancer, actor Joey Fatone to share his AirSculpt experience. AirSculpt is a liposuction procedure that removes fat and tightens skin. It’s offered exclusively at Elite Body Sculpture centers.
- RelabotulinumtoxinA Update from Galdermahttps://modernaesthetics.com/news/relabotulinumtoxina-update-from-galderma/2473504/The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Galderma related to its pending Biologics License Application (BLA) for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity
- Galderma Gives Back: New “Facing Breast Cancer Together" Campaign Supports the National Breast Cancer Foundationhttps://modernaesthetics.com/news/galderma-gives-back-new-facing-breast-cancer-together-campaign-supports-the-national-breast-cancer-foundation/2473503/Galderma is launching a new campaign to provide education and support for breast cancer awareness as part of its nine-year partnership with National Breast Cancer Foundation (NBCF), Inc. The survival rate of breast cancer patients has significantly increased due to early diagnosis
- Merz Aesthetics’ Belotero Balance (+) Receives FDA Approval for Infraorbital Hollowshttps://modernaesthetics.com/news/merz-aesthetics-belotero-balance-receives-fda-approval-for-infraorbital-hollows/2473500/The U.S. Food and Drug Administration (FDA) approved Merz Aesthetics’ Belotero Balance (+) for improvement of the infraorbital hollow (IOH) in adults over the age of 21. This approval stems from positive pivotal study results demonstrating the efficacy and safety of Belotero